BCL2 and cervical cancer: Additionally, Zhang et al. [67] reported that butein can activate FOXO3A, leading to the downregulation of Bcl-2 and upregulation of Bax, which enhances the sensitivity of cervical cancer cells to cisplatin (CDDP).